Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer. - Wikidata - wikimedia - TriplyDB

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer.

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer.

http://www.wikidata.org/entity/Q33407797

about

Chemotherapy beyond second-line in advanced gastric cancer Third-line chemotherapy in advanced gastric cancer: A systematic review and meta-analysis Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma.Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.Design of precise third-line therapy for gastric cancer: target or chemotherpy?5 fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum, anthracycline, and taxane.Second-line treatments: moving towards an opportunity to improve survival in advanced gastric cancer?Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study.

P2860

Q26798288-DA6AB225-5ABE-418C-9965-E0E4FDC655BB Q33818002-7531107E-DEBF-4C06-B072-15E3547FF1FB Q38542060-F75205B2-46DF-48FD-87EE-E44DF30B0A7D Q38599120-718FA4C2-30F6-4587-9E09-69D64CDA7280 Q43162843-2F90A1B8-5EFE-4A77-B8B1-BA69A57695DC Q49895422-992779F3-2587-4215-8FEF-BBFE96103714 Q54970742-0BF341EE-973D-4574-A289-802DE8FBD8F5 Q55379237-2728D0B1-332F-4010-8774-E0C92B98DD8D

P2860

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer.

http://www.wikidata.org/entity/Q33407797

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer.

@ast

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer.

@en

type

label

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer.

@ast

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer.

@en

prefLabel

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer.

@ast

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer.

@en

P1433

Q33407797-67D9483E-0E1D-4E71-A3FC-6582CC3690E3

P1476

Q33407797-05B7A40C-1E9E-4688-BD8D-E4A14C8D7385

P2093

Q33407797-6DCB8C2C-6667-4FC6-9537-3421E7296B79

Q33407797-8C30B5A4-3ABE-45E9-8A71-E96798A635A2

Q33407797-94AE2153-C47B-4AC0-81F4-3D181940B613

Q33407797-9ADC45A0-7B6F-4406-8845-58AAA957DA06

Q33407797-A6A4CDB0-9716-4713-B1FC-D29F5545F77B

Q33407797-AFF9E9F0-BB1B-40D1-9C81-6392A7A675A6

Q33407797-B0DA5D5E-58B3-4E25-A2B8-DF9873744965

P2860

Q33407797-0486CA23-3DBD-44B5-9615-AADEDFAB380B

Q33407797-0BF5FBBD-F299-4105-9E4B-94F51E40656F

Q33407797-0E8F1FA9-F22D-474C-B3BE-6644965C243E

Q33407797-0EFA9456-D722-4E10-A818-AF34B0D93B9D

Q33407797-28E3226B-EE76-4A66-8FAB-2008B7A7EA74

Q33407797-518C2F0B-E150-49FA-8D0B-286649FBA6AE

Q33407797-8AA56453-26C1-4FB4-BE5C-4B400C91AE10

Q33407797-96AB3F0A-4363-4D1A-AF2A-3241CED591AA

Q33407797-9B805BCE-D7AE-443C-AA99-9385FC27D546

Q33407797-9D05DFF7-EF52-402A-98CE-ECCA2DE82AF1

P304

Q33407797-501DCCE2-3A22-42F4-B897-F4D7480CF41D

P31

Q33407797-74497332-D957-4204-837E-BE2025DF68C3

P356

Q33407797-708D9DF7-1C32-4275-9CB0-B9F69F5DABCE

P433

Q33407797-EB7DCC43-85A3-4211-9E9D-FC52707BD122

P478

Q33407797-6DF1D292-0C8F-4086-9AFB-BA55C621B7ED

P577

Q33407797-07C9ED20-EF81-4746-8747-9F7AEEFC8B4A

P5875

Q33407797-B5B400FC-4A57-4356-9135-9E3F36559BB8

P698

Q33407797-445229E3-6B5B-48DA-9659-4497040545C2

P921

Q33407797-7F81850B-FD2E-4B28-B0A3-5A4CAE515954

P932

Q33407797-7CC75579-3924-4BB3-91F3-BD3D54D4EC60

P356

KJIM.2013.28.3.314

P1433

The Korean journal of internal medicine

P1476

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer.

@en

P2093

Hojin Lee

http://www.w3.org/2001/XMLSchema#string

Hye Jung Lee

http://www.w3.org/2001/XMLSchema#string

Hyo-Jin Kim

http://www.w3.org/2001/XMLSchema#string

Ji Hyun Lee

http://www.w3.org/2001/XMLSchema#string

Suee Lee

http://www.w3.org/2001/XMLSchema#string

Sung Yong Oh

http://www.w3.org/2001/XMLSchema#string

Sung-Hyun Kim

http://www.w3.org/2001/XMLSchema#string

P2860

The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density

Taxol suppresses dynamics of individual microtubules in living human tumor cells

Global cancer statistics, 2002

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Oxaliplatin with biweekly low dose leucovorin and bolus and continuous infusion of 5-fluorouracil (modified FOLFOX 4) as a salvage therapy for patients with advanced gastric cancer.

Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatin.

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer.

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer.

Docetaxel for gastric and esophageal carcinomas.

Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design.

P304

314-321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3904/KJIM.2013.28.3.314

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236916692

http://www.w3.org/2001/XMLSchema#string

P698

23682225

http://www.w3.org/2001/XMLSchema#string

P921

P932

3654129

http://www.w3.org/2001/XMLSchema#string